HomeInsightsStock Comparison

Ipca Laboratories Ltd vs Wockhardt Ltd Stock Comparison

Ipca Laboratories Ltd vs Wockhardt Ltd Stock Comparison

Last Updated on: May 14, 2025

Key Highlights

  • The Latest Trading Price of Ipca Laboratories Ltd is ₹ 1404 as of 14 May 10:40.
  • The P/E Ratio of Ipca Laboratories Ltd changed from 28.9 on March 2020 to 57.4 on March 2024 . This represents a CAGR of 14.71% over 5 yearsThe P/E Ratio of Wockhardt Ltd changed from 6.6 on March 2021 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years.
  • The Market Cap of Ipca Laboratories Ltd changed from ₹ 17538 crore on March 2020 to ₹ 31414 crore on March 2024 . This represents a CAGR of 12.36% over 5 yearsThe Market Cap of Wockhardt Ltd changed from ₹ 1912 crore on March 2020 to ₹ 8951 crore on March 2024 . This represents a CAGR of 36.16% over 5 years.
  • The revenue of Ipca Laboratories Ltd for the Dec '24 is ₹ 2265 crore as compare to the Sep '24 revenue of ₹ 2381 crore. This represent the decline of -4.86% The revenue of Wockhardt Ltd for the Dec '24 is ₹ 729 crore as compare to the Sep '24 revenue of ₹ 818 crore. This represent the decline of -10.88%.
  • The ebitda of Ipca Laboratories Ltd for the Dec '24 is ₹ 483.19 crore as compare to the Sep '24 ebitda of ₹ 467.74 crore. This represent the growth of 3.3% The ebitda of Wockhardt Ltd for the Dec '24 is ₹ 136 crore as compare to the Sep '24 ebitda of ₹ 119 crore. This represent the growth of 14.29%.
  • The net profit of Ipca Laboratories Ltd changed from ₹ 166.21 crore to ₹ 277.33 crore over 7 quarters. This represents a CAGR of 33.98% The net profit of Wockhardt Ltd changed from ₹ -136 crore to ₹ 20 crore over 7 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Ipca Laboratories Ltd changed from 9.68 % on March 2020 to 19.13 % on March 2024 . This represents a CAGR of 14.60% over 5 yearsThe Dividend Payout of Wockhardt Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ipca Laboratories Ltd

  • Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
  • The products of the Company are now sold in over 100 countries across the globe.
  • The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries.

About Wockhardt Ltd

  • Wockhardt Limited, incorporated in July, 1999 is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world.
  • The Company is India's leading research-based global healthcare enterprise in fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.
  • It has 12 manufacturing locations and there are 3 locations where research and development activities are carried out. The Company has manufacturing and research facilities in India, USA & UK and a manufacturing facility in Ireland.
  • It has a significant presence in USA, Europe and India, with 83% of its global revenues coming from international businesses.
  • Wockhardt is the only company in the world where USFDA has given QIDP Status (Qualified lnfectious Diseases Programme) for 5 of Anti-bacterial discovery programmes - 2 of them are Gram Negative and 3 Gram Positive effective against untreatable 'Superbugs'.

Ipca Laboratories Ltd News Hub

News

Ipca Laboratories now holds 100% stake in Unichem Laboratories, Ireland

Ipca Laboratories announced that 100% of the paid-up equity share capital of Unichem Labor...

Read more

02 May 2025 11:27

News

Ipca Laboratories appoints President - Human Resources

Ipca Laboratories has appointed Saidutta Nanda as President - Human Resources of the compa...

Read more

03 Mar 2025 16:06

News

Ipca Laboratories Ltd down for fifth straight session

Ipca Laboratories Ltd is down for a fifth straight session today. The stock is quoting at ...

Read more

28 Feb 2025 13:35

News

Ipca Labs spurts after Q3 PAT soars to Rs 267 cr

Revenue from operations jumped 10.34% YoY to Rs 1,662.68 crore in the quarter ended 31st D...

Read more

13 Feb 2025 15:03

News

Ipca Laboratories to announce Quarterly Result

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 13 Febru...

Read more

27 Jan 2025 14:16

News

Ipca Laboratories Ltd spurts 0.49%, rises for fifth straight session

Ipca Laboratories Ltd gained for a fifth straight session today. The stock is quoting at R...

Read more

01 Jan 2025 13:00

Wockhardt Ltd News Hub

News

Wockhardt announces incorporation of step-down subsidiary in Ireland

Wockhardt Bio AG, a subsidiary of Wockhardt, has incorporated a new Wholly Owned Subsidiar...

Read more

08 Apr 2025 19:55

News

Wockhardt surges after breakthrough US cancer treatment with Zaynich

The 15-year-old patient, diagnosed with Acute Myeloid Leukemia (AML), had been battling a ...

Read more

01 Apr 2025 11:32

News

Wockhardt announces board meeting date

Wockhardt will hold a meeting of the Board of Directors of the Company on 7 February 2025....

Read more

03 Feb 2025 16:52

News

Wockhardt spurts after Indian drug regulator approves Pneumonia antibiotic

Miqnaf is an ultra-short course, once-a-day, 3-day treatment for CABP, including those cau...

Read more

03 Jan 2025 11:22

News

Wockhardt to conduct board meeting

Wockhardt will hold a meeting of the Board of Directors of the Company on 13 November 2024...

Read more

08 Nov 2024 16:42

News

Wockhardt slumps on launching QIP at discount

The floor price indicates a steep discount of 8.5% over the stock's closing price on Wedne...

Read more

07 Nov 2024 14:38

SWOT Analysis Of Ipca Laboratories Ltd

Strength

2

S

Weakness

4

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Wockhardt Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ipca Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Wockhardt Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ipca Laboratories Ltd and Wockhardt Ltd

Which company has a larger market capitalization, Ipca Laboratories Ltd or Wockhardt Ltd?

Market cap of Ipca Laboratories Ltd is 35,631 Cr while Market cap of Wockhardt Ltd is 20,768 Cr

What are the key factors driving the stock performance of Ipca Laboratories Ltd and Wockhardt Ltd?

The stock performance of Ipca Laboratories Ltd and Wockhardt Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ipca Laboratories Ltd and Wockhardt Ltd?

As of May 14, 2025, the Ipca Laboratories Ltd stock price is INR ₹1404.45. On the other hand, Wockhardt Ltd stock price is INR ₹1278.2.

How do dividend payouts of Ipca Laboratories Ltd and Wockhardt Ltd compare?

To compare the dividend payouts of Ipca Laboratories Ltd and Wockhardt Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions